TABLE II.
Transmitted Drug Resistance Mutations (TDRs) by Antiretroviral Drug Class
| Patients | NRTIs | NNRTIs | PIs | Subtype |
|---|---|---|---|---|
| 1 | L210W | None | None | F1 |
| 2 | M41L | None | None | F1 |
| 3 | K219Q | None | None | F1 |
| 4 | None | None | M46L | C |
| 5 | M184V | V179F, Y181C | None | F1 |
| 6 | D67N, T69D, K70R, L74I, M184V, T215F, K219Q | None | L24I, M46I, I47V, F53L, I54V, V82A | F1 |
| 7 | K70R | None | None | F1 |
| 8 | D67N, K70R, T215F, K219Q | V106M, Y188C | None | F1 |
| 9 | M184V | None | None | F1 |
NRTIs, nucleoside reverse-transcriptase inhibitors; NNRTIs, non-nucleoside reverse-transcriptase inhibitors; PIs, protease inhibitors.